Garth Lees-Rolfe's Net Worth
$0
Who is Garth Lees-Rolfe?
Garth Lees-Rolfe does not have any significant net worth to report based on the numbers we have. This is based on reported shares in Inhibikase Therapeutics, Inc..
SEC CIK
Garth Lees-Rolfe's CIK is 0002017374
Past Insider Trading and Trends
2024 was Garth Lees-Rolfe's most active year for acquiring shares with 1 total transactions. Garth Lees-Rolfe's most active month to acquire stocks was the month of March. 2024 saw Garth Lees-Rolfe paying a total of $0.00 for 90,000 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Inhibikase Therapeutics, Inc. (IKT) Snapshot price: $1.35
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||